Validation of novel optical imaging technologies: the pathologists' view.

Area of Science:

• Biomedical optics
• Pathology
• Medical imaging

Background:

• Noninvasive optical imaging offers potential for enhanced disease detection and treatment response prediction.
• Pathology is essential for linking optical imaging data to clinical outcomes.
• Validation of optical imaging requires integrating histopathology and advanced tissue analysis.

Purpose of the Study:

• To review the critical role of pathologists in validating optical imaging technologies.
• To outline key considerations for the development and standardization of optical diagnostic tools.
• To emphasize the integration of pathology expertise in optical imaging research.

Main Methods:

• Review of existing literature on optical imaging and pathology validation.
• Discussion on biomarker selection, standardization of tissue processing and analysis.
• Exploration of the pathologist's role in study design and quality control.

Main Results:

• Pathologists are integral to validating optical imaging by providing morphologic and molecular insights.
• Standardization in methods, interpretation, and reporting is crucial for clinical utility.
• The pathologist's role extends to study design, data analysis, and ensuring interobserver reliability.

Conclusions:

• Pathologists play a pivotal role in the validation of noninvasive optical imaging technologies.
• Integrating pathology expertise ensures the clinical relevance, independence, and beneficial value of optical diagnostic tools.
• Standardized approaches and pathologist involvement are key to advancing optical imaging in patient care.